Bone Biologics Corporation (NasdaqCM: BBLG)
Health Care · Biotechnology · US
$0.40
-15.44% today · -84.0% 1Y
Bone Biologics Corporation (NasdaqCM: BBLG) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.09M and employs 2 people.
Over the last twelve months the share price has lost 84.0%, trading between 0.38 and 2.66.
Tweenvest scores Bone Biologics Corporation across four factors: quality 35/100, value 23/100. Its strongest factor is quality.
BBLG price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.09M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.61
- Dividend yield
- —
- Beta (5Y)
- 0.57
- 52-week high
- $2.66
- 52-week low
- $0.38
- Avg volume (3M)
- —
- Shares outstanding
- 2.76M
- Employees
- 2
- Next earnings
- —
About Bone Biologics Corporation
Bone Biologics Corporation, a medical device enterprise, specializes in fostering bone regeneration for spinal fusion, leveraging its advanced recombinant human protein technology. Its flagship product, NELL-1/DBX, is a unique combination of an osteostimulative recombinant protein designed for precise, targeted control over bone regrowth. The company is currently advancing the NELL-1/DBX Fusion Device, intended for spinal fusion interventions in skeletally mature individuals experiencing single-level degenerative disc disease within the L4-S1 spinal segments. This versatile platform technology also holds the potential to deliver superior outcomes across a wide spectrum of surgical specialties, including spinal, various orthopedic fields, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. Bone Biologics holds a licensing agreement with the UCLA Technology Development Group, which authorizes the development and commercialization of NELL-1 for its spinal fusion applications. The firm was established in 2004 and is based in Burlington, Massachusetts.
- ISIN
- US0980706008
- Founded
- 2004
- Listed since
- Oct 13, 2021
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics, Inc.NasdaqCM: LABT | $1.37M | $0.58 | -25.85% |
| Protagenic Therapeutics, Inc.OTCPK: PTIX | $1.36M | $0.75 | -2.60% |
| Premier Biomedical, Inc.OTCPK: BIEI | $1.25M | $0.00 | +5.71% |
| AXIM Biotechnologies, Inc.OTCPK: AXIM | $1.23M | $0.00 | -1.31% |
| Valion Bio, Inc.NasdaqCM: VBIO | $1.04M | $1.17 | -45.33% |
| Halberd CorporationOTCPK: HALB | $941.60K | $0.00 | -3.08% |
| Exousia Bio, Inc.OTCPK: LMMY | $918.75K | $0.02 | +10.06% |
| Aptahem AB (publ)NGM: APTA | $906.66K | Skr— | — |
Figures last refreshed Oct 18, 2026.